Core Insights - A compound called indole-3-carbinol found in cruciferous vegetables enhances the efficacy of immunotherapy by restoring the function of cytotoxic T lymphocytes [1][2] - The study published in Nature Communications indicates that a diet containing indole-3-carbinol significantly improves the response rate to cancer treatment [1] Group 1: Research Findings - Indole-3-carbinol is abundant in vegetables like cabbage and broccoli, and its presence in the diet led to a 50% to 60% effectiveness rate in cancer treatment among animals [1] - When the diet was devoid of indole-3-carbinol, the effectiveness rate dropped to 20% [1] - The research highlights the role of indole-3-carbinol in activating cytotoxic T lymphocytes, which are crucial for targeting and eliminating tumor cells [1][2] Group 2: Mechanism of Action - Indole-3-carbinol binds to a transcription factor known as the "aryl hydrocarbon receptor," which is more prominently expressed in cytotoxic T lymphocytes [2] - In the absence of indole-3-carbinol, cytotoxic T lymphocytes fail to respond to immunotherapy [2] - The findings suggest that dietary components can play a significant role in enhancing anti-tumor immune responses, potentially guiding dietary recommendations for patients undergoing treatment [2]

Core Viewpoint - The study highlights the role of the metabolite Xylulose 5-phosphate (Xu5P) in enhancing the sustained antitumor activity of SLC35E2+ exhausted CD8+ T effector cells, suggesting dietary interventions as a potential treatment for metastatic cancer [3][8]. Group 1: Research Findings - Xu5P promotes the sustained antitumor activity of SLC35E2+ CD8+ exhausted precursor T cells, and its supplementation or consumption of Xu5P-rich foods can synergize with anti-PD-1 therapy to significantly enhance antitumor immune responses [3][7]. - The study identifies Xylulose kinase (XYLB) as a tumor suppressor that generates Xu5P, which enhances the cytotoxicity of CD8+ T cells and inhibits tumor colonization in the lungs [6][8]. - Clinical data indicate that elevated levels of XYLB or increased Xu5P in the blood correlate with enhanced CD8+ T cell efficacy and reduced tumor metastasis [7][8]. Group 2: Mechanism of Action - CD8+ T cells express SLC35E2, which is essential for the transport of Xu5P, thereby maintaining energy/redox homeostasis through the pentose phosphate pathway and glycolysis [7][8]. - Xu5P promotes the generation of SLC35E2+ CD8+ exhausted precursor T cells by mediating TET3-driven DNA demethylation of the Tcf7 promoter, enhancing CD8+ T cell responses [7][8]. - Supplementation with Xu5P or dietary plans rich in Xu5P shows synergistic effects with anti-PD-1 therapy, significantly boosting antitumor immune responses [6][8].